Analysis on recurrence factors associate with giant cell tumor of tendon sheath in upper extremity.
- Author:
Yang-Bo LIU
1
;
Ding-Sheng LIN
;
Jian WANG
;
Huai-Bao ZHANG
;
Lei CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Female; Giant Cell Tumors; pathology; surgery; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; epidemiology; Postoperative Complications; epidemiology; Retrospective Studies; Soft Tissue Neoplasms; pathology; surgery; Tendons; pathology; Upper Extremity
- From: China Journal of Orthopaedics and Traumatology 2011;24(12):988-991
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the relation of the sex, age, location and chemotherapy with recurrence of the tumor.
METHODSFrom January 2000 to August 2010, 47 patients with giant cell tumor of tendon sheath in upper extremity were retrospectively analyzed. Statistical analysis of sex, age at presentation, lesion location, chemical inactivation, surgical complications, tumor recurrence and pathological findings were explored. There were 28 females and 19 males, ranging in age from 17 to 78 years, with an average of 38.15 years. All the patients underwent surgical excision. Fourteen patients received intraoperative chemically inactive treatment. All the patients had routine follow-up to observe the wound healing, pathological findings,tumor recurrence, and received necessary imaging examinations.
RESULTSAll the patients were followed up, and the duration ranged from 22 to 129 months, with a mean time of 53.89 months. Four patients who received intraoperative alcohol inactivation appeared wound complications such as wound swelling, discharge of necrotic tissue, delayed wound healing. Fifteen patients had active growth of tumor tissue, 1 patient had low-grade malignant giant cell tumor of tendon sheath. The recurrence rate was significantly higher in the group which preoperative X-ray was found to have bone destruction (P = 0.003); patients receiving chemically inactivation had lower risk of recurrence after surgery than patients not receiving chemically inactivation (P = 0.042).
CONCLUSIONThe recurrence rate of giant cell tumor of tendon sheath in upper limb was closely related to tumor growth site, bone destruction and chemical inactivation. Local excision of giant cell tumor of tendon sheath was the effective treatment. How to identify the patients at high risk of recurrence, how to reduce the recurrence rate and the functional restoration after wide resection are the priorities and difficulties of future researches.